Panjang
IBOL
Idea only not professional advice
BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers.
2021 First Quarter Operating Highlights (all comparisons are on a year over year basis):
Net revenue grew 70% to $8.1 million with:
Laser system sales increased 139%
Consumables and other revenue increased 52%
U.S. revenue increased 67%
International revenue increased 75%
The gross margin was 34%, up 500 basis points
Maintained a strong balance sheet, as cash and cash equivalents totaled $40.8 million on March 31, 2021, up from $17.6 million on December 31, 2020.
Good reports combined with volume entry, the direction seems to be up
BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers.
2021 First Quarter Operating Highlights (all comparisons are on a year over year basis):
Net revenue grew 70% to $8.1 million with:
Laser system sales increased 139%
Consumables and other revenue increased 52%
U.S. revenue increased 67%
International revenue increased 75%
The gross margin was 34%, up 500 basis points
Maintained a strong balance sheet, as cash and cash equivalents totaled $40.8 million on March 31, 2021, up from $17.6 million on December 31, 2020.
Good reports combined with volume entry, the direction seems to be up
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.